Reticulate Hyperpigmentation secondary to 5-fluorouracil and idarubicin
Jogi, R.; Garman, M.; Pielop, J.; Orengo, I.; Hsu, S.
Journal of Drugs in Dermatology Jdd 4(5): 652-656
2005
ISSN/ISBN: 1545-9616 PMID: 16167426 Document Number: 9801
Although cutaneous reactions from antineoplastic therapy are common, a reticulate pattern of hyperpigmentation has not been frequently reported in the literature. We report 2 cases of reticulate hyperpigmentation associated with cancer chemotherapy with 5-fluorouracil and idarubicin. These 2 cases serve to raise awareness of this particular pattern of hyperpigmentation as a potential side effect of chemotherapeutic regimens.
Document emailed within 1 workday
